Subsequent studies in colon cancer cells found that aspirin, sulindac and sulindac sulfone inhibit NF-κB-dependent transcriptional activity and cause apoptosis, but this was shown to involve initial NF-κB pathway activation through IκBα degradation and NF-κB nuclear translocation [17-19]. This evidence concerns the gene NFKB1 and malignant colon neoplasm.